Startups
Lumos Diagnostics (ASX:LDX) specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.
Overview
Location
United States, Florida, Sarasota
Employees
51-200
Total raised
$15M
Founded date
2004
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 3, 2023 | Lumos Receives US FDA Clearance for FebriDx® | MELBOURNE, Australia, July 3, 2023 /PRNewswire/ -- Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clea... |
| Jul 8, 2021 | Lumos Diagnostics : Raises $63M AUD in ASX IPO | Rapid, point-of-care (POC) diagnostics company, Lumos Diagnostics, today announced it has been admitted to the Australian Securities Exchange (ASX) with trading commencing on July 5 after raising $63 million AUD in an Initial Public Offerin... |
| Apr 6, 2021 | DIASORIN S.P.A. DiaSorin S p A : announces its strategic collaboration with Lumos Diagnostics | DIASORIN IS COLLABORATING WITH LUMOS DIAGNOSTICS TO LAUNCH THE LIAISON® IQ, A NEW IMMUNOASSAY POINT-OF-CARE PLATFORM, AND THE FIRST TWO ASSAYS FOR DECENTRALIZED COVID-19 TESTING DIASORIN ANNOUNCES ITS STRATEGIC COLLABORATION WITH LUMOS DIAG... |
| Oct 7, 2020 | Lumos Diagnostics Raises AU$25M in Pre-IPO Funding | Lumos Diagnostics, a Melbourne, Australia-based rapid point-of-care diagnostics company, closed an AU$25m pre-IPO funding, ahead of an anticipated 2021 Australian Securities Exchange (ASX) listing. The capital was raised from a combination ... |
| Feb 6, 2020 | Lumos Diagnostics raises $15M for rapid, in-office diagnostic testing | The company hopes to have FDA trials of its FebriDx test done this year When we go to the doctor, it's safe to say that most of us want to know three things as soon as possible: if we're actually sick, what we're sick with and how to best t... |
| Feb 5, 2020 | Top tech startup news for today, Wednesday, February 5, 2020: Amazon, LinkedIn, Rad Power Bikes | Good morning! Below are the top tech startups news for today, Wednesday, February 5, 2020. Amazon’s AWS to invest $236 million in Brazil to strengthen cloud infrastructure. Amazon Web Services (AWS), the cloud computing unit of Amazon anno... |
| Feb 5, 2020 | Lumos Diagnostics Raises $15M in Series A Funding | Lumos Diagnostics, a Sarasota, Fla.-based healthcare company that provides complete point-of-care (POC) diagnostic test solutions that utilize proprietary digital reader platforms to allow healthcare professionals to diagnose and manage dis... |
| Feb 5, 2020 | Lumos Diagnostics Raises $15M to Expand Point of Care Diagnostic Solutions Internationally | – Lumos Diagnostics raises $15M in Series A funding to support the international expansion of its point of care diagnostic solutions. – Lumos provides assay development and manufacturing services for customized POC tests as well as directly... |
| Feb 5, 2020 | Lumos Diagnostics raises $15M Series A funding to help healthcare professionals more accurately diagnose and manage diseases | Lumos Diagnostics, an healthtech startup that helps develop and manufacture custom rapid Point-of-Care diagnostic solutions, has secured $15 million in Series A funding to support the international commercial expansion of the FebriDx rapid ... |
Show more
Reviews 0
FAQ about Lumos Diagnostics
When was Lumos Diagnostics founded?
Lumos Diagnostics was founded in 2004.
How much funding has Lumos Diagnostics raised?
Lumos Diagnostics has raised $15M in total across 1 funding round.
What has the press written about Lumos Diagnostics?
Parsers VC has collected 11 articles mentioning Lumos Diagnostics, among them “Lumos Receives US FDA Clearance for FebriDx®” (Jul 3, 2023) and “Lumos Diagnostics : Raises $63M AUD in ASX IPO” (Jul 8, 2021).
Is Lumos Diagnostics still active?
Yes, Lumos Diagnostics is active; its latest activity on Parsers VC dates from Jul 16, 2025.